XTL Biopharmaceuticals Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XTLB research report →
About the company
XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to enter Phase II trials, specifically targeting systemic lupus erythematosus and Sjogren's syndrome.
- CEO
- Noam Band
- IPO
- 2005
- Employees
- 10
- HQ
- Ramat Gan, IL
Price Chart
- Market Cap
- $6.39M
- P/E
- -0.79
- P/S
- 0.00
- P/B
- -22.39
- EV/EBITDA
- -8.24
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -269.02%
- ROIC
- -11253.33%
- Revenue
- $0 · -100.00%
- Net Income
- $-6,969,000 · -578.58%
- EPS
- $-68.00 · 100.00%
- Op Income
- $-1,688,000
- FCF YoY
- 38.70%
- 52W High
- $10.28
- 52W Low
- $2.01
- 50D MA
- $2.62
- 200D MA
- $3.35
- Beta
- 0.56
- Avg Volume
- 1.98M
Get TickerSpark's AI analysis on XTLB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Hillel Fain Osnat | other | 1,000,000 |
| Mar 18, 26 | Segal Niv | other | 0 |
| Nov 18, 08 | EDELMAN JOSEPH | sell | 24,681,360 |
| Nov 18, 08 | EDELMAN JOSEPH | sell | 2,696,450 |
| Nov 19, 08 | EDELMAN JOSEPH | sell | 9,600,000 |
| Nov 18, 08 | EDELMAN JOSEPH | sell | 29,740 |
| Nov 18, 08 | EDELMAN JOSEPH | sell | 400,000 |
| Nov 18, 08 | EDELMAN JOSEPH | sell | 1,943,250 |
| Nov 18, 08 | EDELMAN JOSEPH | sell | 400,000 |
| Nov 18, 08 | EDELMAN JOSEPH | sell | 299,570 |
Our XTLB coverage
Recent articles, reports, and earnings notes.
No research on XTLB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XTLB report →Similar companies
Peers in the same neighborhood.